VEGF inhibitors in metastatic renal cell carcinoma: Current therapies and ... - UroToday PDF Print
UroToday
Metastatic renal cell carcinoma (RCC) is predominantly refractory to treatment with traditional cytotoxic chemotherapies, and until recently management options were limited to immunotherapy, palliative care, or phase I trials.

...

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.